After big buyout, team looks to lead hepatitis B, NASH drug maker to $100M IPO
September 28, 2020 at 17:53 PM EDT
Much of the team that led Alios — without a "g" — to aa $1.8 billion acquisition now is back with Aligos.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|